Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
<p>Abstract</p> <p>Background</p> <p>Current protocols for the treatment of ovarian cancer include combination chemotherapy with a platinating agent and a taxane. However, many patients experience relapse of their cancer and the development of drug resistance is not unc...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | Journal of Ovarian Research |
Subjects: | |
Online Access: | http://www.ovarianresearch.com/content/5/1/40 |